Home / Private raises / NewcelX Ltd.

NewcelX Ltd.

Biotechnology · Kloten, Switzerland · $5.8M sold across 2 offerings

Form D filings (2)

FiledFormSoldOfferedInvestorsExemptionSecuritiesFirst sale
2026-11-18D (new)$2.9M$2.9M5506(b)Equity, Options/warrants, Security to be acquired, Common shares and warrants to purchase common sharesNov 9SEC ↗
2026-08-24D (new)$2.9M$2.9M5506(b)Equity, Options/warrants, Security to be acquired, Common shares and warrants to purchase common sharesJul 3SEC ↗

An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.

Issuer

IndustryBiotechnology
LocatedKloten, Switzerland
EntityOther
IncorporatedSwitzerland
SEC CIK1783036

People named in the latest filing

NameRole
Ronen TwitoExecutive Chairman and Chief Executive Officer
Michel RevelExecutive Officer, Director
Kfir MolakandovExecutive Officer
Omri HagaiChief Financial Officer
Alexander C. ZwyerExecutive Officer, Director
Olivier SamuelDirector
Eran IohanDirector
Liora OrenDirector
Tamar GaliliDirector

Names and roles as filed with the SEC. Addresses are not shown.

Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.

How are we doing?